{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T17:05:53Z","timestamp":1784912753567,"version":"3.55.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Life and Health Guidance Program Project of Dalian"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06571-7","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T14:13:39Z","timestamp":1751465619000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Nordihydroguaiaretic acid inhibits bladder cancer metastasis through suppression of \u03b11,3-mannosyltransferase expression and LRFN4 N-glycosylation"],"prefix":"10.1186","volume":"23","author":[{"given":"Mulin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianya","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6591-8726","authenticated-orcid":false,"given":"Qin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"6571_CR1","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s10495-024-02065-x","volume":"30","author":"D Saini","year":"2025","unstructured":"Saini D, Chaudhary PK, Chaudhary JK, Kaur H, Verma GK, Pramanik SD, et al. Molecular mechanisms of antiproliferative and pro-apoptotic effects of essential oil active constituents in MCF7 and T24 cancer cell lines: in vitro insights and in silico modelling of proapoptotic gene product-compound interactions. Apoptosis. 2025;30:805\u2013825.","journal-title":"Apoptosis"},{"key":"6571_CR2","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.molmed.2024.04.004","volume":"30","author":"R Ben-David","year":"2024","unstructured":"Ben-David R, Galsky MD, Sfakianos JP. Novel bladder-sparing approaches in patients with muscle-invasive bladder cancer. Trends Mol Med. 2024;30:686\u201397.","journal-title":"Trends Mol Med"},{"key":"6571_CR3","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.euo.2023.02.008","volume":"6","author":"E Grobet-Jeandin","year":"2023","unstructured":"Grobet-Jeandin E, Lenfant L, Mir C, Giannarini G, Alcaraz A, Albersen M, et al. A Systematic review of oncological outcomes associated with bladder-sparing strategies in patients achieving complete clinical response to initial systemic treatment for localized muscle-invasive bladder cancer. Eur Urol Oncol. 2023;6:251\u201362.","journal-title":"Eur Urol Oncol"},{"key":"6571_CR4","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.7150\/thno.107213","volume":"15","author":"N Sun","year":"2025","unstructured":"Sun N, Zhang Z, Yang X, Li J, Li Q, Kang J, et al. Unveiling urinary extracellular vesicle mRNA signature for early diagnosis and prognosis of bladder cancer. Theranostics. 2025;15:1272\u201384.","journal-title":"Theranostics"},{"issue":"6","key":"6571_CR5","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.urolonc.2024.12.273","volume":"43","author":"O Abazari","year":"2025","unstructured":"Abazari O, Shahidi M, Dayati P, Valizadeh S, Vahidi S, Tafti MA, et al. Study of urine-based mRNA biomarkers for early detection of nonmuscle invasive bladder cancer (NMIBC). Urol Oncol. 2025;43(6):393.","journal-title":"Urol Oncol"},{"key":"6571_CR6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.urology.2024.11.056","volume":"197","author":"TH Ecke","year":"2025","unstructured":"Ecke TH, Meisl CJ, Schlomm T, Rabien A, Labont\u00e9 F, Rong D, et al. Performance of urinary markers in patients with suspicious cystoscopy during follow-up of recurrent non-muscle invasive bladder cancer: BTA Stat, NMP22 BladderChek, UBC Rapid Test, Cancercheck UBC Rapid VISUAL, and Uromonitor in comparison to cytology. Urology. 2025;197:119\u2013125.","journal-title":"Urology"},{"key":"6571_CR7","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.3390\/cancers16213708","volume":"16","author":"E Carbonell","year":"2024","unstructured":"Carbonell E, Mercader C, Alfambra H, Narvaez P, Villalba E, Pag\u00e8s R, et al. The role of bladder-washing cytology as an adjunctive method to cystoscopy during follow-up for low-grade TaT1 non-muscle-invasive bladder cancer. Cancers. 2024;16:3708.","journal-title":"Cancers"},{"key":"6571_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.eururo.2023.08.016","volume":"85","author":"J Alfred Witjes","year":"2024","unstructured":"Alfred Witjes J, Max Bruins H, Carri\u00f3n A, Cathomas R, Comp\u00e9rat E, Efstathiou JA, et al. European Association of Urology Guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2023 guidelines. Eur Urol. 2024;85:17\u201331.","journal-title":"Eur Urol"},{"key":"6571_CR9","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s12935-024-03492-1","volume":"24","author":"X Sun","year":"2024","unstructured":"Sun X, Wu H, Tang L, Al-Danakh A, Jian Y, Gong L, et al. GALNT6 promotes bladder cancer malignancy and immune escape by epithelial-mesenchymal transition and CD8+ T cells. Cancer Cell Int. 2024;24:308.","journal-title":"Cancer Cell Int"},{"key":"6571_CR10","doi-asserted-by":"publisher","first-page":"4791","DOI":"10.1002\/tox.24333","volume":"39","author":"J Huang","year":"2024","unstructured":"Huang J, Deng H, Xiao S, Lin Y, Yu Z, Xu X, et al. CAB39 modulates epithelial- mesenchymal transition through NF-\u03baB signaling activation, enhancing invasion, and metastasis in bladder cancer. Environ Toxicol. 2024;39:4791\u2013802.","journal-title":"Environ Toxicol"},{"key":"6571_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216807","volume":"593","author":"H Lin","year":"2024","unstructured":"Lin H, Fu L, Zhou X, Yu A, Chen Y, Liao W, et al. LRP1 induces anti-PD-1 resistance by modulating the DLL4-NOTCH2-CCL2 axis and redirecting M2-like macrophage polarisation in bladder cancer. Cancer Lett. 2024;593:216807.","journal-title":"Cancer Lett"},{"key":"6571_CR12","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s10456-023-09876-7","volume":"26","author":"AC Dudley","year":"2023","unstructured":"Dudley AC, Griffioen AW. Pathological angiogenesis: mechanisms and therapeutic strategies. Angiogenesis. 2023;26:313\u201347.","journal-title":"Angiogenesis"},{"key":"6571_CR13","doi-asserted-by":"publisher","first-page":"5201","DOI":"10.1016\/j.apsb.2024.09.005","volume":"14","author":"A Zhao","year":"2024","unstructured":"Zhao A, Zhou C, Li J, Wang Z, Zhu H, Shen S, et al. UBE2G2 inhibits vasculogenic mimicry and metastasis of uveal melanoma by promoting ubiquitination of LGALS3BP. Acta Pharm Sin B. 2024;14:5201\u201318.","journal-title":"Acta Pharm Sin B"},{"key":"6571_CR14","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.apsb.2023.10.014","volume":"14","author":"Y Lin","year":"2024","unstructured":"Lin Y, Lubman DM. The role of N-glycosylation in cancer. Acta Pharm Sin B. 2024;14:1098\u2013110.","journal-title":"Acta Pharm Sin B"},{"key":"6571_CR15","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1002\/cac2.12610","volume":"44","author":"X Xu","year":"2024","unstructured":"Xu X, Peng Q, Jiang X, Tan S, Yang W, Han Y, et al. Altered glycosylation in cancer: molecular functions and therapeutic potential. Cancer Commun. 2024;44:1316\u201336.","journal-title":"Cancer Commun"},{"key":"6571_CR16","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41392-024-01886-1","volume":"9","author":"M He","year":"2024","unstructured":"He M, Zhou X, Wang X. Glycosylation: mechanisms, biological functions and clinical implications. Signal Transduct Target Ther. 2024;9:194.","journal-title":"Signal Transduct Target Ther"},{"key":"6571_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217101","volume":"598","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Li R, Wang W, Zhang H, Zhang Q, Jiang J, et al. O-GlcNAc signaling: implications for stress-induced adaptive response pathway in the tumor microenvironment. Cancer Lett. 2024;598:217101.","journal-title":"Cancer Lett"},{"key":"6571_CR18","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.ajpath.2024.01.022","volume":"194","author":"Y Liu","year":"2024","unstructured":"Liu Y, Cai X, Hu S, Wang Z, Tian H, Wang H. Suppression of N-Glycosylation of zinc finger protein 471 affects proliferation, invasion, and docetaxel sensitivity of tongue squamous cell carcinoma via regulation of c-Myc. Am J Pathol. 2024;194:1106\u201325.","journal-title":"Am J Pathol"},{"key":"6571_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2023.117420","volume":"547","author":"Z Lai","year":"2023","unstructured":"Lai Z, Wang Z, Yuan Z, Zhang J, Zhou J, Li D, et al. Disease-Specific haptoglobin N-Glycosylation in inflammatory disorders between cancers and benign diseases of 3 types of female internal genital organs. Clin Chim Acta. 2023;547:117420.","journal-title":"Clin Chim Acta"},{"key":"6571_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216819","volume":"589","author":"D Zhang","year":"2024","unstructured":"Zhang D, Xie J, Sun F, Xu R, Liu W, Xu J, et al. Pharmacological suppression of HHLA2 glycosylation restores anti-tumor immunity in colorectal cancer. Cancer Lett. 2024;589:216819.","journal-title":"Cancer Lett"},{"key":"6571_CR21","doi-asserted-by":"publisher","first-page":"G697","DOI":"10.1152\/ajpgi.00273.2023","volume":"326","author":"X Li","year":"2024","unstructured":"Li X, Tang X, Xiang Y, Zhao Z, Li Y, Ding Q, et al. N-glycosylation of SCAP exacerbates hepatocellular inflammation and lipid accumulation via ACSS2-mediated histone H3K27 acetylation. Am J Physiol Gastrointest Liver Physiol. 2024;326:G697\u2013711.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"6571_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112875","volume":"140","author":"B Luo","year":"2024","unstructured":"Luo B, Liu X, Zhang Q, Liang G, Zhuang Y. ALG3 predicts poor prognosis and increases resistance to anti-PD-1 therapy through modulating PD-L1 N-link glycosylation in TNBC. Int Immunopharmacol. 2024;140:112875.","journal-title":"Int Immunopharmacol"},{"key":"6571_CR23","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.3390\/cells11193141","volume":"11","author":"X Cui","year":"2022","unstructured":"Cui X, Pei X, Wang H, Feng P, Qin H, Liu S, et al. ALG3 promotes peritoneal metastasis of ovarian cancer through increasing interaction of \u03b11,3-mannosylated uPAR and ADAM8. Cells. 2022;11:3141.","journal-title":"Cells"},{"key":"6571_CR24","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13020-024-01056-z","volume":"20","author":"Y Zhai","year":"2025","unstructured":"Zhai Y, Liu L, Zhang F, Chen X, Wang H, Zhou J, et al. Network pharmacology: a crucial approach in traditional Chinese medicine research. Chin Med. 2025;20:8.","journal-title":"Chin Med"},{"key":"6571_CR25","doi-asserted-by":"publisher","first-page":"1510628","DOI":"10.3389\/fimmu.2024.1510628","volume":"15","author":"H Zhi","year":"2024","unstructured":"Zhi H, Fu H, Zhang Y, Fan N, Zhao C, Li Y, et al. Progress of cGAS-STING signaling pathway-based modulation of immune response by traditional Chinese medicine in clinical diseases. Front Immunol. 2024;15:1510628.","journal-title":"Front Immunol"},{"key":"6571_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2025.107577","volume":"212","author":"Y Liu","year":"2025","unstructured":"Liu Y, Chen J, Li X, Fan Y, Peng C, Ye X, et al. Natural products targeting RAS by multiple mechanisms and its therapeutic potential in cancer: an update since 2020. Pharmacol Res. 2025;212:107577.","journal-title":"Pharmacol Res"},{"key":"6571_CR27","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41392-022-01132-6","volume":"7","author":"GG Jinesh","year":"2022","unstructured":"Jinesh GG, Brohl AS. Classical epithelial-mesenchymal transition (EMT) and alternative cell death process-driven blebbishield metastatic-witch (BMW) pathways to cancer metastasis. Signal Transduct Target Ther. 2022;7:296.","journal-title":"Signal Transduct Target Ther"},{"key":"6571_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107453","volume":"209","author":"XH Zhao","year":"2024","unstructured":"Zhao XH, Ma J, Guo JS, Liu KL, Qin YX, Li LT, et al. Novel deoxyhypusine synthase (DHPS) inhibitors target hypusination-induced vasculogenic mimicry (VM) against malignant melanoma. Pharmacol Res. 2024;209:107453.","journal-title":"Pharmacol Res"},{"key":"6571_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2023.108149","volume":"66","author":"R Bangarh","year":"2023","unstructured":"Bangarh R, Khatana C, Kaur S, Sharma A, Kaushal A, Siwal SS, et al. Aberrant protein glycosylation: implications on diagnosis and immunotherapy. Biotechnol Adv. 2023;66:108149.","journal-title":"Biotechnol Adv"},{"key":"6571_CR30","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1053\/j.gastro.2022.11.018","volume":"164","author":"J Krug","year":"2023","unstructured":"Krug J, Rodrian G, Petter K, Yang H, Khoziainova S, Guo W, et al. N-glycosylation regulates intrinsic IFN-\u03b3 resistance in colorectal cancer: implications for immunotherapy. Gastroenterology. 2023;164:392\u2013406.","journal-title":"Gastroenterology"},{"key":"6571_CR31","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.placenta.2024.03.004","volume":"149","author":"J Liu","year":"2024","unstructured":"Liu J, Dong X, Xie R, Tang Y, Thomas AM, Li S, et al. N-linked \u03b12,6-sialylation of integrin \u03b21 by the sialyltransferase ST6Gal1 promotes cell proliferation and stemness in gestational trophoblastic disease. Placenta. 2024;149:18\u201328.","journal-title":"Placenta"},{"key":"6571_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e18065","volume":"9","author":"Y Yuan","year":"2023","unstructured":"Yuan Y, Xie B, Guo D, Liu C, Jiang G, Lai G, et al. Identification of ALG3 as a potential prognostic biomarker in lung adenocarcinoma. Heliyon. 2023;9:e18065.","journal-title":"Heliyon"},{"key":"6571_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.816102","volume":"9","author":"Z Zhao","year":"2022","unstructured":"Zhao Z, Zheng Z, Huang J, Wang J, Peng T, Lin Y, et al. Expression of ALG3 in hepatocellular carcinoma and its clinical implication. Front Mol Biosci. 2022;9:816102.","journal-title":"Front Mol Biosci"},{"key":"6571_CR34","doi-asserted-by":"publisher","first-page":"1453278","DOI":"10.3389\/fonc.2024.1453278","volume":"14","author":"M Ahangar","year":"2024","unstructured":"Ahangar M, Mahjoubi F, Mowla SJ. Bladder cancer biomarkers: current approaches and future directions. Front Oncol. 2024;14:1453278.","journal-title":"Front Oncol"},{"key":"6571_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2024.108666","volume":"177","author":"Z Wu","year":"2024","unstructured":"Wu Z, Su R, Dai Y, Wu X, Wu H, Wang X, et al. Deep pan-cancer analysis and multi-omics evidence reveal that ALG3 inhibits CD8+ T cell infiltration by suppressing chemokine secretion and is associated with 5-fluorouracil sensitivity. Comput Biol Med. 2024;177:108666.","journal-title":"Comput Biol Med"},{"key":"6571_CR36","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/jimd.12739","volume":"47","author":"EJP Daniel","year":"2024","unstructured":"Daniel EJP, Edmondson AC, Argon Y, Alsharhan H, Lam C, Freeze HH, et al. Deficient glycan extension and endoplasmic reticulum stresses in ALG3-CDG. J Inherit Metab Dis. 2024;47:766\u201377.","journal-title":"J Inherit Metab Dis"},{"key":"6571_CR37","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13075-023-03084-w","volume":"25","author":"H Yu","year":"2023","unstructured":"Yu H, Li M, Shu J, Dang L, Wu X, Wang Y, et al. Characterization of aberrant glycosylation associated with osteoarthritis based on integrated glycomics methods. Arthritis Res Ther. 2023;25:102.","journal-title":"Arthritis Res Ther"},{"key":"6571_CR38","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1080\/17474086.2022.2114894","volume":"15","author":"Z Shang","year":"2022","unstructured":"Shang Z, Ming X, Wu J, Liu W, Xiao Y. CircPTK2 promotes cell viability, cell cycle process, and glycolysis and inhibits cell apoptosis in acute myeloid leukemia by regulating miR-582-3p\/ALG3 axis. Expert Rev Hematol. 2022;15:1073\u201383.","journal-title":"Expert Rev Hematol"},{"key":"6571_CR39","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13046-021-01932-8","volume":"40","author":"X Sun","year":"2021","unstructured":"Sun X, He Z, Guo L, Wang C, Lin C, Ye L, et al. ALG3 contributes to stemness and radioresistance through regulating glycosylation of TGF-\u03b2 receptor II in breast cancer. J Exp Clin Cancer Res. 2021;40:149.","journal-title":"J Exp Clin Cancer Res"},{"key":"6571_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.646818","volume":"12","author":"S Han","year":"2021","unstructured":"Han S, Zhu W, Yang W, Guan Q, Chen C, He Q, et al. A prognostic signature constructed by CTHRC1 and LRFN4 in stomach adenocarcinoma. Front Genet. 2021;12:646818.","journal-title":"Front Genet"},{"key":"6571_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.989141","volume":"13","author":"GC Wang","year":"2023","unstructured":"Wang GC, Zhou M, Zhang Y, Cai HM, Chiang ST, Chen Q, et al. Screening and identifying a novel M-MDSCs-related gene signature for predicting prognostic risk and immunotherapeutic responses in patients with lung adenocarcinoma. Front Genet. 2023;13:989141.","journal-title":"Front Genet"},{"key":"6571_CR42","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41368-024-00289-w","volume":"16","author":"Z Liu","year":"2024","unstructured":"Liu Z, Meng X, Zhang Y, Sun J, Tang X, Zhang Z, et al. FUT8-mediated aberrant N-glycosylation of SEMA7A promotes head and neck squamous cell carcinoma progression. Int J Oral Sci. 2024;16:26.","journal-title":"Int J Oral Sci"},{"key":"6571_CR43","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/s41401-024-01419-0","volume":"46","author":"J Wang","year":"2025","unstructured":"Wang J, Zhang HM, Zhu GH, Zhao LL, Shi J, Dai ZT, et al. STT3-mediated aberrant N-glycosylation of CD24 inhibits paclitaxel sensitivity in triple-negative breast cancer. Acta Pharmacol Sin. 2025;46:1097\u2013110.","journal-title":"Acta Pharmacol Sin"},{"key":"6571_CR44","doi-asserted-by":"publisher","first-page":"7885","DOI":"10.1038\/s41467-024-51831-7","volume":"15","author":"CH Hung","year":"2024","unstructured":"Hung CH, Wu SY, Yao CD, Yeh HH, Lin CC, Chu CY, et al. Defective N-glycosylation of IL6 induces metastasis and tyrosine kinase inhibitor resistance in lung cancer. Nat Commun. 2024;15:7885.","journal-title":"Nat Commun"},{"key":"6571_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156244","volume":"135","author":"HB Li","year":"2024","unstructured":"Li HB, Huang L, Ni JY, Lin RY, Xi SY. Traditional Chinese medicine in the treatment of adverse reactions after TACE for primary hepatic carcinoma: effect, mechanism, and potential advantages. Phytomedicine. 2024;135:156244.","journal-title":"Phytomedicine"},{"key":"6571_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2024.189241","volume":"1880","author":"R Deng","year":"2024","unstructured":"Deng R, Zong GF, Wang X, Yue BJ, Cheng P, Tao RZ, et al. Promises of natural products as clinical applications for cancer. Biochim Biophys Acta Rev Cancer. 2024;1880:189241.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"6571_CR47","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s12943-024-02149-x","volume":"23","author":"AS Huang","year":"2024","unstructured":"Huang AS, Wu J, Amin A, Fu XQ, Yu ZL. Traditional Chinese medicine in treating upper digestive tract cancers. Mol Cancer. 2024;23:250.","journal-title":"Mol Cancer"},{"key":"6571_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.111044","volume":"133","author":"K Wang","year":"2021","unstructured":"Wang K, Chen Q, Shao Y, Yin S, Liu C, Liu Y, et al. Anticancer activities of TCM and their active components against tumor metastasis. Biomed Pharmacother. 2021;133:111044.","journal-title":"Biomed Pharmacother"},{"key":"6571_CR49","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1186\/s13046-022-02559-z","volume":"41","author":"P Yu","year":"2022","unstructured":"Yu P, Wei H, Li K, Zhu S, Li J, Chen C, et al. The traditional Chinese medicine monomer Ailanthone improves the therapeutic efficacy of anti-PD-L1 in melanoma cells by targeting c-Jun. J Exp Clin Cancer Res. 2022;41:346.","journal-title":"J Exp Clin Cancer Res"},{"key":"6571_CR50","doi-asserted-by":"publisher","first-page":"11172","DOI":"10.1039\/D4TB01342E","volume":"12","author":"KM Dhanabalan","year":"2024","unstructured":"Dhanabalan KM, Padhan B, Dravid AA, Agarwal S, Pancheri NM, Lin A, et al. Nordihydroguaiaretic acid microparticles are effective in the treatment of osteoarthritis. J Mater Chem B. 2024;12:11172\u201386.","journal-title":"J Mater Chem B"},{"key":"6571_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiolchem.2024.108285","volume":"115","author":"S Khan","year":"2024","unstructured":"Khan S, Khatri DK. In-silico screening to identify phytochemical inhibitor for hP2X7: a crucial inflammatory cell death mediator in Parkinson\u2019s disease. Comput Biol Chem. 2024;115:108285.","journal-title":"Comput Biol Chem"},{"key":"6571_CR52","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.3390\/v15051155","volume":"15","author":"E Villalobos-S\u00e1nchez","year":"2023","unstructured":"Villalobos-S\u00e1nchez E, Garc\u00eda-Ruiz D, Camacho-Villegas TA, Canales-Aguirre AA, Guti\u00e9rrez-Ortega A, Mu\u00f1oz-Medina JE, et al. In vitro antiviral activity of nordihydroguaiaretic acid against SARS-CoV-2. Viruses. 2023;15:1155.","journal-title":"Viruses"},{"key":"6571_CR53","doi-asserted-by":"publisher","first-page":"34620","DOI":"10.1021\/acsami.4c05311","volume":"16","author":"T Hao","year":"2024","unstructured":"Hao T, Zhang B, Li W, Yang X, Wu S, Yuan Y, et al. Nordihydroguaiaretic acid-cross- linked phenylboronic acid-functionalized polyplex micelles for anti-angiogenic gene therapy of orthotopic and metastatic tumors. ACS Appl Mater Interfaces. 2024;16:34620\u201331.","journal-title":"ACS Appl Mater Interfaces"},{"key":"6571_CR54","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.2174\/0118715273268471231013135114","volume":"23","author":"P Ferrera","year":"2024","unstructured":"Ferrera P, De la Fuente-Mu\u00f1oz CE, Arias C. Nordihydroguaiaretic acid affects undifferentiated and differentiated neuroblastoma cells differently through mechanisms that impact on cell viability. CNS Neurol Disord Drug Targets. 2024;23:1167\u201375.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"6571_CR55","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.intimp.2015.07.016","volume":"28","author":"NA Mundhe","year":"2015","unstructured":"Mundhe NA, Kumar P, Ahmed S, Jamdade V, Mundhe S, Lahkar M. Nordihydroguaiaretic acid ameliorates cisplatin induced nephrotoxicity and potentiates its anti-tumor activity in DMBA induced breast cancer in female Sprague-Dawley rats. Int Immunopharmacol. 2015;28:634\u201342.","journal-title":"Int Immunopharmacol"},{"key":"6571_CR56","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s10549-012-2270-7","volume":"136","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Xu S, Lin J, Yao G, Han Z, Liang B, et al. mTORC1 is a target of nordihydroguaiaretic acid to prevent breast tumor growth in vitro and in vivo. Breast Cancer Res Treat. 2012;136:379\u201388.","journal-title":"Breast Cancer Res Treat"},{"key":"6571_CR57","doi-asserted-by":"publisher","first-page":"11601","DOI":"10.3390\/ijms252111601","volume":"25","author":"C Chip\u00f3n","year":"2024","unstructured":"Chip\u00f3n C, Riffo P, Ojeda L, Salas M, Burgos RA, Ehrenfeld P, et al. Impact of nordihydroguaiaretic acid on proliferation, energy metabolism, and chemosensitization in non-small-cell lung cancer (NSCLC) cell lines. Int J Mol Sci. 2024;25:11601.","journal-title":"Int J Mol Sci"},{"key":"6571_CR58","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1038\/sj.bjc.6600186","volume":"86","author":"T Seufferlein","year":"2002","unstructured":"Seufferlein T, Seckl MJ, Schwarz E, Beil M, Wichert G, Baust H, et al. Mechanisms of nordihydroguaiaretic acid-induced growth inhibition and apoptosis in human cancer cells. Br J Cancer. 2002;86:1188\u201396.","journal-title":"Br J Cancer"},{"key":"6571_CR59","doi-asserted-by":"publisher","first-page":"6830","DOI":"10.1038\/s41467-024-51242-8","volume":"15","author":"Z Shu","year":"2024","unstructured":"Shu Z, Dwivedi B, Switchenko JM, Yu DS, Deng X. PD-L1 deglycosylation promotes its nuclear translocation and accelerates DNA double-strand-break repair in cancer. Nat Commun. 2024;15:6830.","journal-title":"Nat Commun"},{"key":"6571_CR60","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202401649","volume":"13","author":"X Zhang","year":"2024","unstructured":"Zhang X, Li ZY, Xiao JH, Hao PF, Mo J, Zheng XJ, et al. Sialic acids blockade-based chemo-immunotherapy featuring cancer cell chemosensitivity and antitumor immune response synergies. Adv Healthc Mater. 2024;13:e2401649.","journal-title":"Adv Healthc Mater"},{"key":"6571_CR61","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.7150\/ijbs.93806","volume":"20","author":"X Ren","year":"2024","unstructured":"Ren X, Lin S, Guan F, Kang H. Glycosylation targeting: a paradigm shift in cancer immunotherapy. Int J Biol Sci. 2024;20:2607\u201321.","journal-title":"Int J Biol Sci"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06571-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06571-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06571-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T15:02:59Z","timestamp":1751468579000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06571-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6571"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06571-7","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"13 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the First Affiliated Hospital of Dalian Medical University (No. PJ-KS-KY-2022-439), and the written informed consent was obtained from all individuals. Animal experiments were performed and approval by the Animal Ethics Committee of Dalian Medical University (No. AEE23158).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"733"}}